openPR Logo
Press release

Italian Author Daniela Alibrandi launches new Novel "That Sudden Night in Venice"

04-23-2024 08:34 PM CET | Associations & Organizations

Press release from: ABNewswire

Italian Author Daniela Alibrandi launches new Novel "That

Rome, Italy - April 23, 2024 - Acclaimed Italian author Daniela Alibrandi has released her latest novel, "That Sudden Night in Venice," the first book in her new literary series "Scent of Italy." The novel takes readers on a suspenseful journey through the magical city of Venice.

"That Sudden Night in Venice" weaves together storylines of a young aspiring journalist named Chiara who dreams of making it big, a Venice newspaper called "The Voice of the Shadows" struggling to survive, and a renowned South American orchestra conductor named Omar Xantios whose past holds mysteries. The engaging plot unfolds across Venice, Verona, and Treviso as Chiara seeks to interview the famous but reclusive Maestro for her newspaper.

While not a traditional thriller, the novel is full of unpredictable twists and turns that will keep readers captivated amidst the charming backdrop of Venice's canals, piazzas, and architecture. Alibrandi's rich descriptions immerse readers in the magic of one of Italy's most iconic cities.

"I'm thrilled to kick off my 'Scent of Italy' series with this enigmatic story set in Venice," said Alibrandi. "Readers will be transported to the heart of the city's intrigue and history through Chiara's quest to land an interview that could make or break her journalistic dreams."

Daniela Alibrandi is one of Italy's most celebrated authors, having won numerous literary awards such as the Gold Mystery Prize, Yellow Noir Prize, and the prestigious Women Art Week Career Award. Her novels frequently appear at major Italian book fairs and are featured across television and radio broadcasts.

"That Sudden Night in Venice" is available now in [https://www.amazon.com/SUDDEN-NIGHT-VENICE-Scent-Italy/dp/B0CX8L846D/ref=tmm_pap_swatch_0?_encoding=UTF8&dib_tag=se&dib=eyJ2IjoiMSJ9.BWod52R2MsTWL_HNjx-Aaw.yXUsPktI4BvOy780DsGwdiCqogm-ve_P0dGoC3VezYU&qid=1712738935&sr=1-1] and ebook formats on [https://www.amazon.com/SUDDEN-NIGHT-VENICE-Scent-Italy-ebook/dp/B0CWYHYNFJ/ref=tmm_kin_swatch_0?_encoding=UTF8&dib_tag=se&dib=eyJ2IjoiMSJ9.BWod52R2MsTWL_HNjx-Aaw.yXUsPktI4BvOy780DsGwdiCqogm-ve_P0dGoC3VezYU&qid=1712738935&sr=1-1]. The next two books in the "Scent of Italy" series, "Rachel's Child" and "Those Strange Girls" will be released later in 2024.

About Daniela Alibrandi

Born in Rome, Daniela Alibrandi is an accomplished Italian author involved in cultural exchanges across Europe. In addition to "That Sudden Night in Venice," her popular books include award-winners like "Buried Crimes," "Journey to Vienna," "One Death Is Not Enough," and many more captivating novels and short stories.

For more information about Daniela Alibrandi and her works, visit https://danielaalibrandi.com or follow her on Facebook and other social channels.

English website: [https://danielaenglishwebsite.wordpress.com/]

Italian website: [https://danielaalibrandi.com/]

Facebook: Daniela Alibrandi Author Page

For media inquiries, interview requests, or review copies, please contact:

Daniela Alibrandi

Email: daniela53.alibrandi@outlook.it

Phone: +39 3478709323 (WhatsApp)

Media Contact
Company Name: Daniela Alibrandi
Contact Person: Daniela Alibrandi
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=italian-author-daniela-alibrandi-launches-new-novel-that-sudden-night-in-venice]
Country: Italy
Website: https://danielaalibrandi.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Italian Author Daniela Alibrandi launches new Novel "That Sudden Night in Venice" here

News-ID: 3473957 • Views:

More Releases from ABNewswire

Dualentry Explains Why AI Won't Replace Accountants but Will Transform Accounting Forever
Dualentry Explains Why AI Won't Replace Accountants but Will Transform Accountin …
Ask CFOs if artificial intelligence will eliminate their departments, and you'll trigger an immediate defensive reaction. Of course not; someone needs to ensure compliance, interpret complex standards, make judgment calls. Yet while they're defending their teams, something remarkable is happening: JPMorgan Chase just eliminated 360,000 hours of annual legal document review work with a single AI platform. PwC announced a $1 billion three-year investment to expand and scale its AI capabilities, including
Combat Veteran-Physician's MedEq Fitness Empowers Holiday Health Transformations After $250K Launch Triumph
12-10-2025 | Sports
ABNewswire
Combat Veteran-Physician's MedEq Fitness Empowers Holiday Health Transformations …
MedEq Fitness's complete wellness ecosystem, from hyperbaric chambers to ice plunges, captures holiday market after generating $250,000 in first 90 days. The physician-combat veteran founder's personal long COVID recovery story drives mission to democratize advanced wellness technology. MedEq Fitness transforms the landscape of home wellness following its remarkable $250,000 revenue generation in just 90 days, as the physician and combat veteran-founded company capitalizes on surging holiday demand for comprehensive health solutions
Marginal Zone Lymphoma Treatment Pipeline Shows Strong Momentum as 50+ Pharma Companies in the Race | DelveInsight
Marginal Zone Lymphoma Treatment Pipeline Shows Strong Momentum as 50+ Pharma Co …
DelveInsight's "Marginal Zone Lymphoma Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Marginal Zone Lymphoma therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Download DelveInsight's
Polycythemia Vera Clinical Trial Pipeline Shows Potential with Active Contributions from 8+ Key Companies | DelveInsight
Polycythemia Vera Clinical Trial Pipeline Shows Potential with Active Contributi …
DelveInsight's, "Polycythemia Vera Pipeline Insight 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Polycythemia Vera pipeline landscape. It covers the Polycythemia Vera pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Polycythemia Vera therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options

All 5 Releases